Therefore, the collective data suggest CD34+CLDN5+ ECs promoted the development of CCA and recruited MSCs into TME, with these ECs exhibiting elevated expression of IGF2 within the tumor. This evidence concerns the gene CLDN5 and cholangiocarcinoma.